Technology float CurveBeam AI graduates to ASX
Key Points
- Why it matters: CurveBeam raised $25 million at 48¢ a share valuing it at $153.7 million.
- Fund managers such as SG Hiscock have backed the med tech float.
Medical imaging technology business CurveBeam AI has convinced fund managers to back its ASX debut with the prospect of strong sales growth in the US healthcare market predicated on more accurate osteoarthritis diagnoses.
The software developer, which had its origins at Melbourne University in 2009, will float on Wednesday after raising $25 million at 48¢ a share in its initial public offering, for an implied market value of $153.7 million.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Equity markets
Fetching latest articles